ERF is a potent inhibitor of the PKB/Akt signaling pathway in leukemic and lymphoma cell lines [35,36,37,39,41], whereas the natural product curcumin is a well-known proteasome inhibitor of NF-κB [75,76,77,78]. Here, AKT1 is linked to lymphoma.